1.
Pissa M, Helkkula T, Appelqvist F, Silander G, Borgquist Åke, Pettersson J, et al. CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015–2020: implications for novel national recommendations. AO [Internet]. 2021 Jul. 3 [cited 2026 Jun. 20];60(7):888-96. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/23994